NRIX Nurix Therapeutics, Inc.
Nasdaq · SEC CIK 1549595 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $4.53M 32 sales by 3 insiders
- Filings on record
- 197 since 2021-07-02, latest 2026-09-02 19:42
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Ring Christine | CLO | — | $3.26M |
| van Houte Hans | CFO | — | $635.3K |
| Hansen Gwenn | CSO | — | $630.9K |
Transactions 233
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-02 19:42 | 2026-09-02 | NRIX | Ring Christine | CLO | M - OptEx | $8.72 | +5,787 | 14.9K | +64% | +$50.5K |
| DMT | 2026-09-02 19:42 | 2026-09-02 | NRIX | Ring Christine | CLO | S - Sale+OE | $25.76 | -5,787 | 9,110 | -39% | -$149.1K |
| DT | 2026-09-01 17:19 | 2026-09-01 | NRIX | Hansen Gwenn | CSO | M - OptEx | $1.86 | +1,452 | 118.7K | +1% | +$2,701 |
| DT | 2026-09-01 17:19 | 2026-09-01 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $25.47 | -1,452 | 117.2K | -1% | -$37.0K |
| DT | 2026-08-05 18:59 | 2026-08-05 | NRIX | Hansen Gwenn | CSO | M - OptEx | $1.86 | +4,356 | 121.6K | +4% | +$8,102 |
| DT | 2026-08-05 18:59 | 2026-08-05 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $25.00 | -4,356 | 117.2K | -4% | -$108.9K |
| MT | 2026-08-05 06:39 | 2026-08-04 | NRIX | Hansen Gwenn | CSO | S - Sale | $24.36 | -4,111 | 117.2K | -3% | -$100.1K |
| MT | 2026-08-04 21:41 | 2026-08-04 | NRIX | van Houte Hans | CFO | S - Sale | $24.36 | -4,761 | 40.2K | -11% | -$116.0K |
| DT | 2026-08-03 17:51 | 2026-08-03 | NRIX | Ring Christine | CLO | M - OptEx | $8.72 | +5,787 | 25.7K | +29% | +$50.5K |
| DT | 2026-08-03 17:51 | 2026-08-03 | NRIX | Ring Christine | CLO | S - Sale+OE | $23.05 | -16.6K | 9,110 | -65% | -$382.4K |
| DM | 2026-07-30 17:58 | 2026-07-30 | NRIX | van Houte Hans | CFO | M - OptEx | $0.00 | +10.2K | 47.8K | +27% | $0 |
| D | 2026-07-30 17:58 | 2026-07-30 | NRIX | van Houte Hans | CFO | S - Sale+OE | $23.38 | -2,845 | 44.9K | -6% | -$66.5K |
| DM | 2026-07-30 17:56 | 2026-07-30 | NRIX | Ring Christine | CLO | M - OptEx | $0.00 | +10.2K | 23.8K | +75% | $0 |
| D | 2026-07-30 17:56 | 2026-07-30 | NRIX | Ring Christine | CLO | S - Sale+OE | $23.38 | -3,847 | 19.9K | -16% | -$90.0K |
| DM | 2026-07-30 17:50 | 2026-07-30 | NRIX | Hansen Gwenn | CSO | M - OptEx | $0.00 | +10.2K | 125.2K | +9% | $0 |
| D | 2026-07-30 17:50 | 2026-07-30 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $23.38 | -3,847 | 121.3K | -3% | -$90.0K |
| DMT | 2026-07-02 18:02 | 2026-07-02 | NRIX | Ring Christine | CLO | M - OptEx | $5.47 | +11.0K | 24.6K | +81% | +$60.2K |
| DT | 2026-07-02 18:02 | 2026-07-02 | NRIX | Ring Christine | CLO | S - Sale+OE | $23.56 | -11.0K | 13.6K | -45% | -$259.4K |
| T | 2026-06-25 18:49 | 2026-06-25 | NRIX | Hansen Gwenn | CSO | S - Sale | $20.00 | -5,394 | 115.0K | -4% | -$107.9K |
| DMT | 2026-06-25 18:38 | 2026-06-25 | NRIX | Ring Christine | CLO | M - OptEx | $8.05 | +28.9K | 42.5K | +213% | +$232.8K |
| DT | 2026-06-25 18:38 | 2026-06-25 | NRIX | Ring Christine | CLO | S - Sale+OE | $20.06 | -28.9K | 13.6K | -68% | -$580.5K |
| DT | 2026-06-02 19:14 | 2026-06-02 | NRIX | Ring Christine | CLO | M - OptEx | $1.86 | +3,422 | 21.7K | +19% | +$6,365 |
| DT | 2026-06-02 19:14 | 2026-06-02 | NRIX | Ring Christine | CLO | S - Sale+OE | $16.60 | -8,148 | 13.6K | -38% | -$135.3K |
| MT | 2026-05-05 19:53 | 2026-05-05 | NRIX | van Houte Hans | CFO | S - Sale | $16.60 | -14.1K | 37.6K | -27% | -$233.3K |
| T | 2026-05-04 18:10 | 2026-05-04 | NRIX | Ring Christine | CLO | S - Sale | $16.96 | -8,148 | 18.3K | -31% | -$138.2K |
| T | 2026-05-01 17:50 | 2026-05-01 | NRIX | Ring Christine | CLO | S - Sale | $16.76 | -5,394 | 26.5K | -17% | -$90.4K |
| DM | 2026-04-30 17:38 | 2026-04-30 | NRIX | van Houte Hans | CFO | M - OptEx | $0.00 | +8,608 | 54.0K | +19% | $0 |
| D | 2026-04-30 17:38 | 2026-04-30 | NRIX | van Houte Hans | CFO | S - Sale+OE | $16.65 | -2,388 | 51.6K | -4% | -$39.7K |
| DM | 2026-04-30 17:37 | 2026-04-30 | NRIX | Ring Christine | CLO | M - OptEx | $0.00 | +8,608 | 35.1K | +33% | $0 |
| D | 2026-04-30 17:37 | 2026-04-30 | NRIX | Ring Christine | CLO | S - Sale+OE | $16.65 | -3,214 | 31.8K | -9% | -$53.5K |
| DM | 2026-04-30 17:35 | 2026-04-30 | NRIX | Hansen Gwenn | CSO | M - OptEx | $0.00 | +8,608 | 123.6K | +7% | $0 |
| D | 2026-04-30 17:35 | 2026-04-30 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $16.65 | -3,214 | 120.4K | -3% | -$53.5K |
| T | 2026-04-02 19:02 | 2026-04-02 | NRIX | Ring Christine | CLO | S - Sale | $15.24 | -8,148 | 26.5K | -24% | -$124.1K |
| 2026-03-02 | 2026-03-02 | NRIX | Ring Christine | CLO | S - Sale | $15.44 | -8,148 | 34.6K | -19% | -$125.8K | |
| 2026-02-09 | 2026-02-09 | NRIX | Ring Christine | CLO | S - Sale | $16.66 | -14.3K | 42.7K | -25% | -$237.6K | |
| D | 2026-02-03 | 2026-02-03 | NRIX | Hansen Gwenn | CSO | M - OptEx | $0.84 | +31.3K | 115.0K | +37% | +$26.3K |
| DM | 2026-01-30 | 2026-01-30 | NRIX | Ring Christine | CLO | M - OptEx | $0.00 | +10.5K | 58.6K | +22% | $0 |
| DM | 2026-01-30 | 2026-01-30 | NRIX | Ring Christine | CLO | S - Sale+OE | $16.60 | -4,421 | 57.1K | -7% | -$73.4K |
| DM | 2026-01-30 | 2026-01-30 | NRIX | van Houte Hans | CFO | M - OptEx | $0.00 | +11.5K | 46.2K | +33% | $0 |
| DM | 2026-01-30 | 2026-01-30 | NRIX | van Houte Hans | CFO | S - Sale+OE | $16.60 | -3,661 | 45.5K | -7% | -$60.8K |
| DM | 2026-01-30 | 2026-01-30 | NRIX | Hansen Gwenn | CSO | M - OptEx | $0.00 | +11.8K | 85.7K | +16% | $0 |
| DM | 2026-01-30 | 2026-01-30 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $16.60 | -4,895 | 83.8K | -6% | -$81.2K |
| D | 2026-01-20 | 2026-01-20 | NRIX | Ring Christine | CLO | M - OptEx | $1.86 | +3,760 | 54.7K | +7% | +$6,994 |
| D | 2026-01-20 | 2026-01-20 | NRIX | Ring Christine | CLO | S - Sale+OE | $18.42 | -3,760 | 50.9K | -7% | -$69.3K |
| DM | 2025-12-18 | 2025-12-18 | NRIX | Ring Christine | CLO | S - Sale+OE | $17.91 | -3,760 | 50.9K | -7% | -$67.3K |
| D | 2025-12-18 | 2025-12-18 | NRIX | Ring Christine | CLO | M - OptEx | $1.86 | +3,760 | 54.7K | +7% | +$6,994 |
| D | 2025-11-24 | 2025-11-24 | NRIX | Ring Christine | CLO | S - Sale+OE | $17.07 | -37.6K | 50.9K | -42% | -$641.8K |
| D | 2025-11-24 | 2025-11-24 | NRIX | Ring Christine | CLO | M - OptEx | $1.86 | +37.6K | 88.5K | +74% | +$69.9K |
| 2025-11-03 | 2025-11-03 | NRIX | van Houte Hans | CFO | S - Sale | $12.56 | -6,284 | 37.6K | -14% | -$78.9K | |
| DM | 2025-10-30 | 2025-10-30 | NRIX | Hansen Gwenn | CSO | M - OptEx | $0.00 | +11.8K | 74.2K | +19% | $0 |
| D | 2025-10-30 | 2025-10-30 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $12.80 | -4,087 | 76.8K | -5% | -$52.3K |
| DM | 2025-10-30 | 2025-10-30 | NRIX | van Houte Hans | CFO | M - OptEx | $0.00 | +11.5K | 38.4K | +43% | $0 |
| D | 2025-10-30 | 2025-10-30 | NRIX | van Houte Hans | CFO | S - Sale+OE | $12.80 | -3,130 | 43.9K | -7% | -$40.1K |
| DM | 2025-10-30 | 2025-10-30 | NRIX | Ring Christine | CLO | M - OptEx | $0.00 | +10.5K | 51.7K | +26% | $0 |
| D | 2025-10-30 | 2025-10-30 | NRIX | Ring Christine | CLO | S - Sale+OE | $12.80 | -3,644 | 50.9K | -7% | -$46.6K |
| D | 2025-09-17 | 2025-09-17 | NRIX | GREGORY JULIA P | Dir | M - OptEx | $1.86 | +10.8K | 10.8K | New | +$20.0K |
| 2025-08-01 | 2025-08-01 | NRIX | van Houte Hans | CFO | S - Sale | $11.03 | -5,402 | 35.5K | -13% | -$59.6K | |
| DM | 2025-07-30 | 2025-07-30 | NRIX | van Houte Hans | CFO | M - OptEx | $0.00 | +11.5K | 45.2K | +34% | $0 |
| D | 2025-07-30 | 2025-07-30 | NRIX | van Houte Hans | CFO | S - Sale+OE | $12.01 | -4,304 | 40.9K | -10% | -$51.7K |
| D | 2025-07-30 | 2025-07-30 | NRIX | Ring Christine | CLO | S - Sale+OE | $12.01 | -3,841 | 44.0K | -8% | -$46.1K |
| DM | 2025-07-30 | 2025-07-30 | NRIX | Ring Christine | CLO | M - OptEx | $0.00 | +10.5K | 41.2K | +34% | $0 |
| DM | 2025-07-30 | 2025-07-30 | NRIX | Hansen Gwenn | CSO | M - OptEx | $0.00 | +11.8K | 64.7K | +22% | $0 |
| D | 2025-07-30 | 2025-07-30 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $12.01 | -4,308 | 69.0K | -6% | -$51.7K |
| 2025-05-02 | 2025-05-02 | NRIX | van Houte Hans | CFO | S - Sale | $11.33 | -6,198 | 33.7K | -16% | -$70.2K | |
| DM | 2025-04-30 | 2025-04-30 | NRIX | Ring Christine | CLO | M - OptEx | $0.00 | +7,674 | 34.5K | +29% | $0 |
| D | 2025-04-30 | 2025-04-30 | NRIX | Ring Christine | CLO | S - Sale+OE | $11.50 | -2,894 | 37.3K | -7% | -$33.3K |
| DM | 2025-04-30 | 2025-04-30 | NRIX | Hansen Gwenn | CSO | M - OptEx | $0.00 | +8,956 | 59.1K | +18% | $0 |
| D | 2025-04-30 | 2025-04-30 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $11.50 | -3,377 | 61.5K | -5% | -$38.8K |
| DM | 2025-04-30 | 2025-04-30 | NRIX | van Houte Hans | CFO | M - OptEx | $0.00 | +8,636 | 42.4K | +26% | $0 |
| D | 2025-04-30 | 2025-04-30 | NRIX | van Houte Hans | CFO | S - Sale+OE | $11.50 | -2,438 | 39.9K | -6% | -$28.0K |
| M | 2025-03-03 | 2025-03-03 | NRIX | van Houte Hans | CFO | S - Sale | $14.49 | -5,825 | 34.4K | -14% | -$84.4K |
| DM | 2025-02-03 | 2025-01-31 | NRIX | Ring Christine | CLO | M - OptEx | $1.86 | +5,760 | 38.3K | +18% | +$10.7K |
| DM | 2025-02-03 | 2025-01-31 | NRIX | Ring Christine | CLO | S - Sale+OE | $19.95 | -5,760 | 32.6K | -15% | -$114.9K |
| DM | 2025-01-30 | 2025-01-30 | NRIX | van Houte Hans | CFO | M - OptEx | $0.00 | +8,636 | 42.4K | +26% | $0 |
| DM | 2025-01-30 | 2025-01-30 | NRIX | van Houte Hans | CFO | S - Sale+OE | $19.86 | -2,811 | 39.8K | -7% | -$55.8K |
| DM | 2025-01-30 | 2025-01-30 | NRIX | Ring Christine | CLO | M - OptEx | $0.00 | +7,674 | 30.0K | +34% | $0 |
| DM | 2025-01-30 | 2025-01-30 | NRIX | Ring Christine | CLO | S - Sale+OE | $19.86 | -3,220 | 32.8K | -9% | -$63.9K |
| DM | 2025-01-30 | 2025-01-30 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $19.86 | -3,690 | 55.9K | -6% | -$73.3K |
| DM | 2025-01-30 | 2025-01-30 | NRIX | Hansen Gwenn | CSO | M - OptEx | $0.00 | +8,957 | 53.9K | +20% | $0 |
| D | 2025-01-02 | 2025-01-02 | NRIX | Ring Christine | CLO | M - OptEx | $1.86 | +5,760 | 33.8K | +21% | +$10.7K |
| D | 2025-01-02 | 2025-01-02 | NRIX | Ring Christine | CLO | S - Sale+OE | $19.50 | -5,760 | 28.1K | -17% | -$112.3K |
| D | 2024-12-02 | 2024-12-02 | NRIX | Ring Christine | CLO | S - Sale+OE | $21.73 | -5,760 | 28.1K | -17% | -$125.2K |
| D | 2024-12-02 | 2024-12-02 | NRIX | Ring Christine | CLO | M - OptEx | $1.86 | +5,760 | 33.8K | +21% | +$10.7K |
| D | 2024-11-04 | 2024-11-04 | NRIX | Ring Christine | CLO | S - Sale+OE | $25.00 | -3,290 | 28.1K | -10% | -$82.2K |
| D | 2024-11-04 | 2024-11-04 | NRIX | Ring Christine | CLO | M - OptEx | $9.57 | +3,290 | 31.4K | +12% | +$31.5K |
| D | 2024-11-01 | 2024-11-01 | NRIX | Ring Christine | CLO | S - Sale+OE | $24.28 | -5,760 | 28.1K | -17% | -$139.9K |
| D | 2024-11-01 | 2024-11-01 | NRIX | Ring Christine | CLO | M - OptEx | $1.86 | +5,760 | 33.8K | +21% | +$10.7K |
| 2024-11-01 | 2024-11-01 | NRIX | van Houte Hans | CFO | S - Sale | $24.28 | -3,546 | 33.7K | -10% | -$86.1K | |
| D | 2024-10-30 | 2024-10-30 | NRIX | Ring Christine | CLO | S - Sale+OE | $24.31 | -4,182 | 28.1K | -13% | -$101.7K |
| DM | 2024-10-30 | 2024-10-30 | NRIX | Ring Christine | CLO | M - OptEx | $0.00 | +7,674 | 26.5K | +41% | $0 |
| D | 2024-10-30 | 2024-10-30 | NRIX | van Houte Hans | CFO | S - Sale+OE | $24.31 | -2,368 | 37.3K | -6% | -$57.6K |
| DM | 2024-10-30 | 2024-10-30 | NRIX | van Houte Hans | CFO | M - OptEx | $0.00 | +8,636 | 33.9K | +34% | $0 |
| DM | 2024-10-30 | 2024-10-30 | NRIX | Hansen Gwenn | CSO | M - OptEx | $0.00 | +8,957 | 50.4K | +22% | $0 |
| D | 2024-10-30 | 2024-10-30 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $24.31 | -3,437 | 50.7K | -6% | -$83.6K |
| D | 2024-10-15 | 2024-10-14 | NRIX | Ring Christine | CLO | S - Sale+OE | $25.00 | -3,290 | 24.6K | -12% | -$82.2K |
| D | 2024-10-15 | 2024-10-14 | NRIX | Ring Christine | CLO | M - OptEx | $9.57 | +3,290 | 27.9K | +13% | +$31.5K |
| D | 2024-10-01 | 2024-10-01 | NRIX | Ring Christine | CLO | M - OptEx | $1.86 | +5,760 | 30.4K | +23% | +$10.7K |
| DM | 2024-10-01 | 2024-10-01 | NRIX | Ring Christine | CLO | S - Sale+OE | $22.22 | -5,760 | 24.6K | -19% | -$128.0K |
| DM | 2024-09-03 | 2024-09-03 | NRIX | Ring Christine | CLO | S - Sale+OE | $24.95 | -9,050 | 24.8K | -27% | -$225.8K |
| DM | 2024-09-03 | 2024-09-03 | NRIX | Ring Christine | CLO | M - OptEx | $4.66 | +9,050 | 30.4K | +42% | +$42.2K |
Purchase Sale Sale after option exercise All abbreviations